What does CUSIP 29664W105 represent in this 13F holders report?

CUSIP 29664W105 is the security identifier for ESPR - Esperion Therapeutics, Inc. - COM used to aggregate holder disclosures.

How many institutions held ESPR - Esperion Therapeutics, Inc. - COM in Q2 2017?

129 institutional investors reported ESPR - Esperion Therapeutics, Inc. - COM for Q2 2017. Use the holders table for investor-level position and value details.

Esperion Therapeutics, Inc. - COM (ESPR)

CUSIP: 29664W105

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / COM
Shares outstanding: 258,506,508
Total 13F shares: 20,787,063
Share change: +2,958,026
Total reported value: $962,036,441
Put/Call ratio: 377%
Price per share: $46.28
Number of holders: 129
Value change: +$142,703,625
Number of buys: 62
Number of sells: 62

Quarterly Holders Quick Answers

What is CUSIP 29664W105?
CUSIP 29664W105 identifies ESPR - Esperion Therapeutics, Inc. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 29664W105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Pentwater Capital Management LP	13F	Company	0.71%	1,836,200	$64,836,000	—	31 Mar 2017	13F
BB BIOTECH AG	13F	Company	0.54%	1,408,542	$49,736,000	—	31 Mar 2017	13F
FMR LLC	13F	Company	0.51%	1,308,588	$46,206,000	—	31 Mar 2017	13F
BlackRock Finance, Inc.	13F	Company	0.5%	1,281,944	$45,265,000	—	31 Mar 2017	13F
Boxer Capital, LLC	13F	Company	0.49%	1,275,000	$45,020,000	—	31 Mar 2017	13F
CREDIT SUISSE AG/	13F	Company	0.34%	878,823	$31,030,000	—	31 Mar 2017	13F
Aisling Capital LLC	13F	Company	0.32%	837,125	$29,559,000	—	31 Mar 2017	13F
PINNACLE ASSOCIATES LTD	13F	Company	0.3%	770,618	$27,211,000	—	31 Mar 2017	13F
WASATCH ADVISORS LP	13F	Company	0.3%	766,543	$27,067,000	—	31 Mar 2017	13F
VANGUARD GROUP INC	13F	Company	0.28%	724,150	$25,569,000	—	31 Mar 2017	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	0.27%	704,701	$24,883,000	—	31 Mar 2017	13F
Rhenman & Partners Asset Management AB	13F	Company	0.21%	543,347	$19,186,000	—	31 Mar 2017	13F
NORTHERN TRUST CORP	13F	Company	0.2%	523,610	$18,489,000	—	31 Mar 2017	13F
STATE STREET CORP	13F	Company	0.16%	413,222	$14,592,000	—	31 Mar 2017	13F
DISCOVERY CAPITAL MANAGEMENT, LLC / CT	13F	Company	0.15%	381,530	$13,472,000	—	31 Mar 2017	13F
PDT Partners, LLC	13F	Company	0.12%	315,100	$11,126,000	—	31 Mar 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.12%	306,155	$10,808,000	—	31 Mar 2017	13F
PAULSON & CO. INC.	13F	Company	0.09%	231,800	$8,185,000	—	31 Mar 2017	13F
GAM Holding AG	13F	Company	0.09%	225,000	$7,945,000	—	31 Mar 2017	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.07%	187,152	$6,608,337	—	31 Mar 2017	13F
JPMORGAN CHASE & CO	13F	Company	0.07%	183,908	$6,493,000	—	31 Mar 2017	13F
Quantitative Investment Management, LLC	13F	Company	0.06%	166,900	$5,893,000	—	31 Mar 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.05%	136,521	$4,820,000	—	31 Mar 2017	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.05%	128,542	$4,539,000	—	31 Mar 2017	13F
Informed Momentum Co LLC	13F	Company	0.05%	128,300	$4,530,000	—	31 Mar 2017	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.04%	110,475	$3,901,000	—	31 Mar 2017	13F
Bank of New York Mellon Corp	13F	Company	0.04%	104,603	$3,693,000	—	31 Mar 2017	13F
UBS Group AG	13F	Company	0.04%	101,131	$3,571,000	—	31 Mar 2017	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.04%	94,117	$3,323,000	—	31 Mar 2017	13F
Crawford Lake Capital Management, LLC	13F	Company	0.04%	93,551	$3,303,000	—	31 Mar 2017	13F
Antipodean Advisors LLC	13F	Company	0.04%	91,000	$3,213,000	—	31 Mar 2017	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.03%	90,118	$3,182,000	—	31 Mar 2017	13F
MORGAN STANLEY	13F	Company	0.03%	77,539	$2,737,000	—	31 Mar 2017	13F
Iguana Healthcare Management, LLC	13F	Company	0.03%	75,000	$2,648,000	—	31 Mar 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.02%	61,883	$2,185,000	—	31 Mar 2017	13F
GROUP ONE TRADING LLC	13F	Company	0.02%	58,312	$2,059,000	—	31 Mar 2017	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.02%	57,435	$2,028,000	—	31 Mar 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	55,129	$1,947,000	—	31 Mar 2017	13F
EQUITEC PROPRIETARY MARKETS, LLC	13F	Company	0.02%	52,593	$1,857,000	—	31 Mar 2017	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.02%	49,500	$1,748,000	—	31 Mar 2017	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.02%	48,762	$1,722,000	—	31 Mar 2017	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.02%	42,391	$1,498,000	—	31 Mar 2017	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.02%	41,900	$1,479,000	—	31 Mar 2017	13F
BAILARD, INC.	13F	Company	0.02%	41,000	$1,448,000	—	31 Mar 2017	13F
Nationwide Fund Advisors	13F	Company	0.02%	39,286	$1,387,000	—	31 Mar 2017	13F
Virtu KCG Holdings LLC	13F	Company	0.02%	39,196	$1,384,000	—	31 Mar 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.01%	37,926	$1,339,000	—	31 Mar 2017	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.01%	36,328	$1,283,000	—	31 Mar 2017	13F
Bellevue Group AG	13F	Company	0.01%	32,000	$1,130,000	—	31 Mar 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.01%	31,761	$1,121,000	—	31 Mar 2017	13F

Institutional Holders of Esperion Therapeutics, Inc. - COM (ESPR) as of Q2 2017

As of 30 Jun 2017, Esperion Therapeutics, Inc. - COM (ESPR) was held by 129 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,787,063 shares. The largest 10 holders included Pentwater Capital Management LP, BB BIOTECH AG, STATE STREET CORP, FMR LLC, BlackRock Inc., CREDIT SUISSE AG/, Boxer Capital, LLC, DISCOVERY CAPITAL MANAGEMENT, LLC / CT, Aisling Capital LLC, and VANGUARD GROUP INC. This page lists 129 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

116

Q2 2017 holders

129

Holder diff

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 Value $	Q2 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.